A Study of Anti-PD-1 AK105 in Patients With Metastatic Nonsquamous Non-small Cell Lung Cancer

Clinical trial NCT03866980 · TERMINATED

Trial details

NCT number: NCT03866980
Sponsor: Akeso
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Cancer Non-small Cell Stage IV

Start date: 2018-11-27
Primary completion: 2023-06-30
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.